Ackermann AL, Frank LA, McEntee MF and May ER (2015). Erythema multiforme assosiated with zonisamide in a dog. Veterinary Dermatology 26, 391–392

Boothe DM, Perkins J and Dewey C (2005) Clinical pharmacokinetics and safety of the anticonvulsant zonisamide in healthy dogs following single and multiple dosing. Proceedings of the 23rd ACVIM forum, Baltimore, USA

Brandifino M, Sinnott-Stutzman V, Sisson A and Whelan M (2022) Presumed zonisamide-induced blood dyscrasias in four dogs. Journal of Veterinary Emergency and Critical Care 32, 805–811

Brewer DM, Cerda-Gonzalez S, Dewey CW et al. (2014) Pharmacokinetics of single-dose rectal zonisamide administration in normal dogs. Journal of Veterinary Internal Medicine 29, 603–606

Budsberg SC (2004) Zonisamide therapy for refractory idiopathic epilepsy in dogs. Journal of the American Animal Hospital Association 40, 285–291

Chung JY, Hwang CY, Chae JS et al. (2012) Zonisamide monotherapy for idiopathic epilepsy in dogs. New Zealand Veterinary Journal 60 , 357–359

Cook AK, Allen AK, Espinosa D and Barr J (2011) Renal tubular acidosis associated with zonisamide therapy in a dog. Journal of Veterinary Internal Medicine 25, 1454–1457

Dewey CW, Guiliano R, Boothe DM et al. (2004) Zonisamide therapy for refractory idiopathic epilepsy in dogs. Journal of the American Animal Hospital Association 40, 285–291

Djani DM, Liou M, Aravamuthan S, Lau V and Cameron S (2024) A retrospective study on the efficay of zonisamide in controlling seizures in 57 cats. Journal of Veterinary Internal Medicine 38, 1092–1100

Gadde KM, Franciscy DM, Wagner HR 2^nd and Krishnan KR (2003) Zonisamide for weight loss in obese adults: a randomized controlled trial. Journal of the American Medical Association 289, 1820–1825

Hasegawa D, Kobayashi M, Kuwabara T et al. (2008) Pharmacokinetics and toxicity of zonisamide in cats. Journal of Feline Medicine and Surgery 10, 418–421

Kanazono S, Ukai M and Hiramoto A (2021) Abnormal behavioural episodes associated with zonisamide in three dogs: a case report. Frontiers in Veterinary Science 8, 763822

von Klopmann T, Rambeck B and Tipold A (2007) A study of zonisamide therapy for refractory idiopathic epilepsy in dogs. Journal of Small Animal Practice 48 , 134–138

Miller ML, Center SA, Randolph JF et al. (2011) Apparent acute idiosyncratic hepatic necrosis associated with zonisamide administration in a dog. Journal of Veterinary Internal Medicine 25, 1156–1160

Orito K, Saito M, Fukunaga K et al. (2008) Pharmacokinetics of zonisamide and drug interaction with phenobarbital in dogs. Journal of Veterinary Pharmacology and Therapeutics 31, 259–264

Saito M, Nomura A, Hasegawa D et al. (2024) Clinical efficacy and tolerability of zonisamide monotherapy in dogs with newly diagnosed idiopathic epilepsy: Prospective open - label uncontrolled multicenter trial. Journal of Veterinary Internal Medicine 38, 2228–2236

Schwartz M, Muñana KR and Olby NJ (2011) Possible drug-induced hepatopathy in a dog receiving zonisamide monotherapy for treatment of cryptogenic epilepsy. Journal of Veterinary Medical Scie nce 73, 1505–1508

Smith TK, Cameron S, Trepanier LA (2022) Incidence of hepatopathies in dogs administered zonisamide orally: a retrospective study of 384 cases. Journal of Veterinary Medical Scie nce 36, 576–579

Walker RM, DiFonzo CJ, Barsoum NJ et al. (1988) Chronic toxicity of the anticonvulsant zonisamide in beagle dogs. Fundamental and applied Toxicology 11, 333–342